The state's treasurer is taking on drugmakers Novo Nordisk and Eli Lilly in an attempt to lower drug costs for the state. So far, neither side is satisfied.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
